The frequency of mutations within the four major pathways varied markedly across genetic subtypes with a striking association of B-cell development/differentiation and JAK2 mutations with leukemias expressing a BCR-ABL1-like gene expression profile and of Ras signaling pathway mutations with cases defined by a distinct gene expression profile coupled with focal ERG deletion [53]. Here, JAK2 is linked to leukemia.